Assaf, C. “Zanolimumab (HuMax-CD4®), a Fully Human Monoclonal Antibody in Clinical Development for Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 2, no. 5, June 2009, doi:10.4081/hmr.v2i5.736.